Senior IT Auditor
Posted on: 3 Apr 2021
Cambridge, MA
Job Description
Job Description
About This Role
The scope of work for this role may include pre and post system implementation reviews, application control reviews, IT operational audits, assessments of cybersecurity controls, and audits of compliance with applicable regulations (e.g. SOX, GDPR).
What Youll Do
Support IT internal audits, maturity assessments, and advisory engagements.
Key role in engagement planning and fieldwork testing.
Communicate directly with management to validate audit observations.
Follow-up with management on status of remediation plans.
Ensure audit documentation adheres to professional and department quality standards.
Coordinate with finance and compliance audit teams on integrated audits.
Testing of ITGCs as part of SOX compliance program.
Assist with development and execution of data analytics program.
Support investigations of cybersecurity incidents.
Other activities as assigned to support department goals and objectives.
Qualifications
Required Skills
2-3 years of experience in an internal audit department or IT risk advisory practice.
Work experience should indicate progressively more responsibility.
Foundational knowledge of audit methodology, risk assessment and internal control concepts.
Foundational understanding of IT risk, processes, and controls.
Foundational understanding of IT process and control frameworks (ITIL, COBIT, NIST, PMBOK).
Familiarity with cybersecurity, privacy, and cloud computing concepts.
Proficient written and verbal communication skills.
Proficient organizational and project management skills.
Self-motivated, able to work in a team and independently.
Bachelors degree in business, information systems, or other relevant field.
Preferred Skills
Professional certifications preferred CISA, CISM, CISSP, CRISC, CIA.
Life Sciences industry experience considered to be a plus.
Familiarity with Oracle ERP a plus.
Additional Information
Why Biogen?
Our mission to find therapies for neurological and rare diseases is a unique focus within our industry and this shared purpose is what connects us as a team. We work together to overcome obstacles and to follow the science. We are resilient as we strive to make an impact on our patients lives and on changing the course of medicine. Together, we pioneer. Together, we thrive.
Biogen
Cambridge, MA
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; and IMRALDI, an adalimumab biosimilar referencing HUMIRA. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies.
Further, it is involved in developing BIIB098, Opicinumab, and BIIB061 for MS and neuroimmunology; Aducanumab, Elenbecestat, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB092 and BIIB054 for treating Parkinson's disease and movement disorders; BIIB067, BIIB078, and BIIB110 to treat neuromuscular disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB104 for treating neurocognitive disorders; BIIB074 and BIIB095 for pain; and Dapirolzumab pegol, BG00011, and BIIB059 for treating other diseases, which are under various stages of development.
The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc., Eisai Co., Ltd., Alkermes Pharma Ireland Limited, Bristol-Myers Squibb Company, Acorda Therapeutics, Inc., AbbVie Inc., C4 Therapeutics, University of Pennsylvania, Applied Genetic Technologies Corporation, and others. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
IndustryBiotechnology
-
No. of Employees7,800
-
Website
-
Jobs Posted445
